This PhD project will examine untreated remission from alcohol problems. This will involve understanding the way in which those with alcohol problems engage in ‘spontaneous remission’ or ‘natural recovery’ outside the treatment setting.
In 2016 the ACT committed to scoping and designing a Drug and Alcohol Court (DAC).
This is a PhD project of Vivienne Moxham-Hall (supervised by Professor Alison Ritter and Dr Caitlin Hughes) investigating the utility of indexes as a measure of drug policy.
This is the PhD project of Ms Shann Hulme.
National and international evidence indicates that the non-medical use of pharmaceutical drugs is increasing, along with the associated health, social and economic harms.
Over the past few years, there has been a significant increase in the number of seizures and unintentional overdose fatalities related to illicit synthetic opioids in multiple states across the U.S.
This project attempts to understand the global epidemiology of infectious disease among prisoners in all countries.
This project is an international collaboration to assess the nature and extent of health outcomes from drug cryptomarkets, globally and specifically for Australians.
Cannabis remains one of the most commonly used psychoactive substances in the United States, and current epidemiological studies indicate broadening acceptability. This aim of this project is to decrease the burden of psychoactive substance use in the US.
To reduce alcohol related harms, the World Health Organisation recommends regulating the sale and supply of alcohol, including limiting the number of premises selling alcohol as well as the hours during which alcohol can be sold.
This project will review the evidence for the medicinal use of cannabis and cannabinoid products for a number of key medical conditions.
